Insight Molecular Diagnostics, Inc. (IMDX)
7.50
+0.50
(+7.14%)
USD |
NASDAQ |
Dec 31, 16:00
7.50
0.00 (0.00%)
After-Hours: 20:00
Insight Molecular Diagnostics Free Cash Flow: -23.91M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| FONAR Corp. | 7.016M |
| XWELL, Inc. | -15.12M |
| ProPhase Labs, Inc. | -11.15M |
| Veracyte, Inc. | 98.21M |
| Exagen, Inc. | -10.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.502M |
| Cash from Investing (Quarterly) | -1.05M |
| Cash from Financing (Quarterly) | -0.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1733 |
| Free Cash Flow to Equity (Quarterly) | -5.305M |
| Free Cash Flow to Firm (Quarterly) | -5.523M |
| Free Cash Flow Yield | -11.90% |